insights_auto
Why is INO down 2,15%?
Dive Deeperchevron_right
INO:NASDAQ
Inovio Pharmaceuticals Inc
0,88 $
arrow_downward
-2,15%(-0,019) 1D
26 қаз., 14:20:36 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INO...
Open
0,92 $
High
0,94 $
Low
0,87 $
Mkt. cap
90,47 млн
Avg. vol.
3,56 млн
Volume
1,88 млн
52-wk high
2,72 $
52-wk low
0,57 $
EPS
-1,17 $
Beta
1,61
Shares outstanding
103,40 млн
No. of employees
112
Open
0,92 $
High
0,94 $
Low
0,87 $
Mkt. cap
90,47 млн
Avg. vol.
3,56 млн
Volume
1,88 млн
52-wk high
2,72 $
52-wk low
0,57 $
EPS
-1,17 $
Beta
1,61
Shares outstanding
103,40 млн
No. of employees
112
News stories
From web sources and news partners
Foreign Policy Journal
·
37 минут бұрын
SpaceX's 80,000 Cell Site Expansion Signals Gains For AST SpaceMobile (NASDAQ: ASTS), Ericsson (NASDAQ: ERIC), Nokia (NYSE: NOK) And NextNav (NASDAQ: NN), Roth Capital Says
24/7 Wall St.
·
3 минут бұрын
$1,000 in This Boring Stock Grew to $9,427. The S&P 500 Couldn’t Keep Up
The National
·
16 минут бұрын
Wall St looks for best day in month as Anthropic's IPO filing propels AI stocks
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc